Peter Sullivan

GOP leaders will bring "consensus" bills to the floor to lower health care costs, but an ACA fix is not among them.

Two key Republican chairmen circulated the plan as the GOP struggles to unite around health policies.

The move enshrines a top agenda item of vaccine critics as government policy.

Biotech and pharmaceutical companies rely on the FDA for guidance as they spend huge sums developing treatments.

The internal memo comes after an internal agency review linked COVID-19 vaccines to the deaths of 10 children.

Trump wrote on Tuesday morning that Congress shouldn't "waste your time" on anything like a subsidy extension.

Some in Congress are still hoping for a bipartisan deal to extend the ACA subsidies.

GOP risks a political bludgeoning and key Democrats are facing the ire of their party.

It could be a major letdown for many Democrats who made ACA financial assistance a centerpiece of the shutdown fight.

Negotiators like Shaheen have a few weeks to find a compromise.

Republicans say health care negotiations with Democrats won't take place until the shutdown ends.

The insurer would pass discounts to patients at the pharmacy counter.

Extending the credits after Nov. 1 is still possible, experts say, but gets much harder if there are massive changes.

The measure targets a provision that Democrats say is a costly handout to major pharmaceutical companies.

The nine treatments that could be evaluated in one to two months under the streamlined process.

Sticker shock could lead many Americans to conclude health coverage is out of reach.

The vote shows how national security concerns are making their way into the health care sector.

The decision adds to conservative scrutiny of the agency and Commissioner Marty Makary.

The tax credits that help people afford premiums are at the center of the showdown over government funding.

The Trump administration is facing conflicting political pressures over Kennedy's recent move.